Association Between 18F-FDG PET/CT and Thyroglobulin Doubling-Time in Differentiated Thyroid Carcinoma

被引：0
|
作者：
Costa, G. [1 ]
Lapa, P. [1 ]
Martins, H. [1 ]
Albuquerque, A. [1 ]
Pedroso de Lima, J. [1 ,2 ]
机构：
[1] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
[2] Inst Ciencias Nucl Aplicadas & Saude, Coimbra, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPW41
引用
收藏
页码：S222 / S223
页数：2
相关论文
共 50 条
  • [31] 18F-FDG PET/CT must be included in the initial staging of patients with high risk differentiated thyroid carcinoma
    Ucmak, Gulin
    Demirel, Busra
    Akkas, Burcu
    Fidan, Aykut
    Ercakmak, Nur
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [32] Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [18F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
    Domenico Albano
    Mark Tulchinsky
    Francesco Dondi
    Angelica Mazzoletti
    Davide Lombardi
    Francesco Bertagna
    Raffaele Giubbini
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 461 - 468
  • [33] Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [18F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma
    Albano, Domenico
    Tulchinsky, Mark
    Dondi, Francesco
    Mazzoletti, Angelica
    Lombardi, Davide
    Bertagna, Francesco
    Giubbini, Raffaele
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) : 461 - 468
  • [34] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, Elgin
    Soydal, Cigdem
    Kucuk, Ozlem N.
    Ibis, Erkan
    Erbay, Guner
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [35] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, E.
    Soydal, C.
    Kucuk, O. N.
    Ibis, E.
    Erbay, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S347 - S347
  • [36] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, Elgin
    Soydal, Cigdem
    Kucuk, Ozlem N.
    Ibis, Erkan
    Erbay, Guner
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (12) : 1162 - 1168
  • [37] The role of 18F-FDG PET/CT testing in the management of a papillary thyroid carcinoma
    Agnieszka Florczak
    Andrea d'Amico
    [J]. Thyroid Research, 6 (Suppl 2)
  • [38] 18F-FDG-PET-CT in patients with differentiated thyroid carcinoma, elevated thyroglobulin and negative 131I scan
    Mendez, D. R.
    Rodado, S.
    Santos, I.
    Hernandez, I.
    Couto, R.
    Marin, M.
    Coronado, M.
    Martin Curto, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S563 - S563
  • [39] The role of Thyroglobulin doubling time in the follow up of differentiated thyroid cancer and its relationship with demographic and histopathologic risk factors and with 18F FDG PET/CT parameters
    Araz, M.
    Soydal, C.
    Ozkan, E.
    Akkus, P.
    Nak, D.
    Kucuk, O. N.
    Kir, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S561 - S561
  • [40] 18F-FDG PET/CT of Transitional Cell Carcinoma
    Patil, Vivek V.
    Wang, Zhen J.
    Sollitto, Richard A.
    Chuang, Kai-Wen
    Konety, Badrinath R.
    Hawkins, Randy A.
    Coakley, Fergus V.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (06) : W497 - W504
12345